State to raise ₹ 1,050 cr through sale of securities


The State government has decided to raise another ₹ 1,050 crore from the Reserve Bank of India by sale of securities to meet its immediate financial requirements.

The government did not opt for the green shoe option so far as it has been doing since the past couple of months, but the tenure of the loan remained at 30 years. The government has bid for the amount which will be mobilized through auction of securities. The auction, to be held through e-Kuber platform of the RBI, will be held on Tuesday and payment by successful bidders would be made the next day.

Meanwhile, the Central government informed that Telangana’s share of Central taxes has been fixed at ₹ 11,731.76 crore for the current financial year according to the revised estimates. Of the total quantum, the Centre had released ₹ 7,927.1 crore to the State till December and the releases were to the tune of ₹ 9,473.89 crore till February-end.

The releases of States’ share/tax devolution was as per the accepted recommendations of the Finance Commission for its award period. Of the ₹ 5.49 lakh crore devolution to States as per revised estimates, the Centre has released ₹ 4.44 lakh crore till February, Union Minister of State for Finance Anurag Singh Thakur said in reply to a query in Parliament. He was responding to a query on the amount of Central taxes which were shared/divided between the Centre and State governments.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

Lancet publishes Covaxin phase 2 trials data | India News – Times of India

HYDERABAD: A week after Bharat Biotech and Indian Council of Medical Research (ICMR) announced that India’s first indigenous Covid-19 vaccine Covaxin, (codenamed BBV152) has shown an interim efficacy of nearly 81%, prestigious medical journal The Lancet has now published Phase 2 clinical trial results of the vaccine candidate. The results of the study titled ‘Safety […]

%d bloggers like this: